ArticleInternational journal of cardiology. Cardiovascular risk and prevention2025
Walking as a viable alternative to moderate-to-vigorous physical activity for improving cardiovascular outcomes in coronary artery disease patients.
Article in International journal of cardiology. Cardiovascular risk and prevention, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Home-based cardiac rehabilitation is recommended for coronary artery disease (CAD) patients, while exercise is the most important component. There is lack of evidence on whether walking alone can improve cardiovascular prognosis in CAD patients, particularly those unable to tolerate moderate-to-vigorous physical activity (MVPA). Methods: Participants with diagnosed CAD from the UK Biobank with baseline PA assessment were included. PA data, including total PA, MVPA, and walking, were collected using the International Physical Activity Questionnaire, and expressed as the total metabolic equivalent of tasks minutes per week. We accessed the association between PA and cardiovascular composite outcome (cardiac death, heart failure hospitalization, non-fatal myocardial infarction, percutaneous coronary intervention, coronary artery bypass grafting) and all-cause mortality. Result: Over a median follow-up of 13.5 years, incidence of all-cause mortality (21.6, 16.7, 15.9, 15.6 per 1000 person-years) and cardiovascular composite events (20.6, 17.8, 17.8, 17.2 per 1000 person-years) decreased with increasing time of total PA in 19,074 patients. Notably, for patients who did not meet AHA/ESC/WHO recommendations, achieving an adequate amount of walking (100 min/week) reduced risk of cardiovascular composite outcome (HR = 0.84, 95 %CI [0.71-0.99], p = 0.038) and all-cause mortality (HR = 0.84, 95 %CI [0.77-0.91], p < 0.001). In patients with lower levels of PA, replacing 30 min per day of sedentary behavior with walking or MVPA reduced all-cause mortality risk. Conclusion: In this large cohort, prolonged exercise duration, including total PA, MVPA and walking, may reduce the cardiovascular risks for CAD patients. For patients unable to tolerate MVPA, walking may serve as a suitable alternative.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.